Profiling the Urinary Microbiota in Male Patients With Bladder Cancer in China/Experiment 1
Subjects
- Location of subjects
- China
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Homo sapiens
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Urine Urine,urine
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Bladder carcinoma bladder cancer,bladder carcinoma,cancer of bladder,cancer of the bladder,cancer of the urinary bladder,cancer of urinary bladder,carcinoma bladder,carcinoma of bladder,carcinoma of the bladder,carcinoma of the urinary bladder,carcinoma of urinary bladder,urinary bladder cancer,urinary bladder carcinoma,Bladder carcinoma
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- non-neoplastic (controls)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Bladder cancer
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Male patients with bladder cancer
- Group 0 sample size Number of subjects in the control (unexposed) group
- 18
- Group 1 sample size Number of subjects in the case (exposed) group
- 31
- Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
- Within one month
Lab analysis
- Sequencing type
- 16S
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- V4
- Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
- Illumina
Statistical Analysis
- Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
- relative abundances
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.05
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- Yes
- LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
- 2.00
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Chao1 Abundance-based estimator of species richness
- increased
- Simpson Estimator of species richness and species evenness: more weight on species evenness
- unchanged
- Richness Number of species
- increased
- Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
- increased
Signature 1
Source: Figure 4 B.
Description: Microbial taxa associated with bladder cancer. (B) Association of specific microbiota taxa with cancer group and non-cancer group by linear discriminant analysis effect size (LEfSe). Red indicates taxa enriched in cancer group and green indicates taxa enriched in non-cancer group.
Abundance in Group 1: increased abundance in Bladder cancer
Revision editor(s): Ayibatari
Signature 2
Source: Figure 4 B.
Description: Microbial taxa associated with bladder cancer. (B) Association of specific microbiota taxa with cancer group and non-cancer group by linear discriminant analysis effect size (LEfSe). Red indicates taxa enriched in cancer group and green indicates taxa enriched in non-cancer group.
Abundance in Group 1: decreased abundance in Bladder cancer
Revision editor(s): Ayibatari
